Survivin, a cancer target with an emerging role in normal adult tissues
S Fukuda, LM Pelus - Molecular cancer therapeutics, 2006 - AACR
Survivin, an inhibitor of apoptosis protein, is highly expressed in most cancers and
associated with chemotherapy resistance, increased tumor recurrence, and shorter patient …
associated with chemotherapy resistance, increased tumor recurrence, and shorter patient …
[HTML][HTML] Peripheral blood stem cell mobilization: the CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties
LM Pelus, S Fukuda - Experimental hematology, 2006 - Elsevier
Chemokines direct the movement of leukocytes, including hematopoietic stem and
progenitor cells, and can mobilize hematopoietic cells from marrow to peripheral blood …
progenitor cells, and can mobilize hematopoietic cells from marrow to peripheral blood …
Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: implication of …
S Fukuda, LM Pelus - Blood, The Journal of the American …, 2001 - ashpublications.org
The inhibitor-of-apoptosis protein survivin is expressed in most cancers and leukemias and
during fetal development, but not in most normal adult tissues. Survivin expression was …
during fetal development, but not in most normal adult tissues. Survivin expression was …
Essential role of signal transducer and activator of transcription (Stat) 5a but not Stat5b for Flt3-dependent signaling
S Zhang, S Fukuda, Y Lee, G Hangoc… - The Journal of …, 2000 - rupress.org
The receptor tyrosine kinase Flt3 plays an important role in proliferation and survival of
hematopoietic stem and progenitor cells. Although some post-receptor signaling events of …
hematopoietic stem and progenitor cells. Although some post-receptor signaling events of …
Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ …
LM Pelus, H Bian, AG King, S Fukuda - Blood, 2004 - ashpublications.org
Mobilized peripheral blood stem cells (PBSCs) are widely used for transplantation, but
mechanisms mediating their release from marrow are poorly understood. We previously …
mechanisms mediating their release from marrow are poorly understood. We previously …
Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase
S Tomatsu, S Fukuda, M Masue, K Sukegawa… - Biochemical and …, 1991 - Elsevier
We cloned and sequenced a full-length cDNA of human placental N-acetylgalactosamine-6-
sulfate sulfatase, the enzyme deficient in Morquio disease. The 2339-nucleotide sequence …
sulfate sulfatase, the enzyme deficient in Morquio disease. The 2339-nucleotide sequence …
[HTML][HTML] Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: selective screening …
N Shibata, Y Hasegawa, K Yamada… - Molecular genetics and …, 2018 - Elsevier
Background Expanded newborn screening (ENBS) utilizing tandem mass spectrometry
(MS/MS) for inborn metabolic diseases (IMDs), such as organic acidemias (OAs), fatty acid …
(MS/MS) for inborn metabolic diseases (IMDs), such as organic acidemias (OAs), fatty acid …
Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability
C Mantel, Y Guo, MR Lee, MK Kim, MK Han… - Blood, 2007 - ashpublications.org
Karyotypic abnormalities in cultured embryonic stem cells (ESCs), especially near-diploid
aneuploidy, are potential obstacles to ESC use in regenerative medicine. Events causing …
aneuploidy, are potential obstacles to ESC use in regenerative medicine. Events causing …
[PDF][PDF] Rapid mobilization reveals a highly engraftable hematopoietic stem cell
J Hoggatt, P Singh, TA Tate, BK Chou, SR Datari… - Cell, 2018 - cell.com
Hematopoietic stem cell transplantation is a potential curative therapy for malignant and
nonmalignant diseases. Improving the efficiency of stem cell collection and the quality of the …
nonmalignant diseases. Improving the efficiency of stem cell collection and the quality of the …
Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1α (CXCL12)/CXCR4 axis
S Fukuda, HE Broxmeyer, LM Pelus - Blood, 2005 - ashpublications.org
Flt3 ligand (FL) enhances hematopoietic cell proliferation and facilitates hematopoietic stem
cell mobilization in vivo, while the stromal-derived factor 1α (SDF-1α, CXC ligand 12 …
cell mobilization in vivo, while the stromal-derived factor 1α (SDF-1α, CXC ligand 12 …